These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 38835755)

  • 21. Characterization of systemic and pneumonic murine models of plague infection using a conditionally virulent strain.
    Mellado-Sanchez G; Ramirez K; Drachenberg CB; Diaz-McNair J; Rodriguez AL; Galen JE; Nataro JP; Pasetti MF
    Comp Immunol Microbiol Infect Dis; 2013 Mar; 36(2):113-28. PubMed ID: 23195858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.
    Lin JS; Kummer LW; Szaba FM; Smiley ST
    J Immunol; 2011 Feb; 186(3):1675-84. PubMed ID: 21172869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral vaccination against plague using Yersinia pseudotuberculosis.
    Demeure CE; Derbise A; Carniel E
    Chem Biol Interact; 2017 Apr; 267():89-95. PubMed ID: 27046452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Toll-Like Receptor-Specific Agonists on the Host Immune Response to the
    Biryukov S; Dankmeyer JL; Shamsuddin Z; Velez I; Rill NO; Rosario-Acevedo R; Klimko CP; Shoe JL; Hunter M; Ward MD; Cazares LH; Fetterer DP; Bozue JA; Worsham PL; Cote CK; Amemiya K
    Front Immunol; 2021; 12():726416. PubMed ID: 34512658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection.
    Philipovskiy AV; Smiley ST
    Infect Immun; 2007 Feb; 75(2):878-85. PubMed ID: 17118978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.
    Sabhnani L; Manocha M; Sridevi K; Shashikiran D; Rayanade R; Rao DN
    FEMS Immunol Med Microbiol; 2003 Oct; 38(3):215-29. PubMed ID: 14522457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection Elicited by Attenuated Live
    Cote CK; Biryukov SS; Klimko CP; Shoe JL; Hunter M; Rosario-Acevedo R; Fetterer DP; Moody KL; Meyer JR; Rill NO; Dankmeyer JL; Worsham PL; Bozue JA; Welkos SL
    Vaccines (Basel); 2021 Feb; 9(2):. PubMed ID: 33669472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection Induced by Oral Vaccination with a Recombinant
    Majumder S; Olson RM; Singh A; Wang X; Li P; Kittana H; Anderson PE; Anderson DM; Sun W
    Infect Immun; 2022 Aug; 90(8):e0016522. PubMed ID: 35900096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE; Butcher WA; Titball RW; Hill J
    Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Yersinia pestis biovar Microtus strain 201, an avirulent strain to humans, provides protection against bubonic plague in rhesus macaques.
    Zhang Q; Wang Q; Tian G; Qi Z; Zhang X; Wu X; Qiu Y; Bi Y; Yang X; Xin Y; He J; Zhou J; Zeng L; Yang R; Wang X
    Hum Vaccin Immunother; 2014; 10(2):368-77. PubMed ID: 24225642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral vaccination with salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague.
    Yang X; Hinnebusch BJ; Trunkle T; Bosio CM; Suo Z; Tighe M; Harmsen A; Becker T; Crist K; Walters N; Avci R; Pascual DW
    J Immunol; 2007 Jan; 178(2):1059-67. PubMed ID: 17202369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current challenges in the development of vaccines for pneumonic plague.
    Smiley ST
    Expert Rev Vaccines; 2008 Mar; 7(2):209-21. PubMed ID: 18324890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Yersinia pestis with regulated delayed attenuation as a vaccine candidate to induce protective immunity against plague.
    Sun W; Roland KL; Kuang X; Branger CG; Curtiss R
    Infect Immun; 2010 Mar; 78(3):1304-13. PubMed ID: 20086087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.
    Sha J; Kirtley ML; Klages C; Erova TE; Telepnev M; Ponnusamy D; Fitts EC; Baze WB; Sivasubramani SK; Lawrence WS; Patrikeev I; Peel JE; Andersson JA; Kozlova EV; Tiner BL; Peterson JW; McWilliams D; Patel S; Rothe E; Motin VL; Chopra AK
    Clin Vaccine Immunol; 2016 Jul; 23(7):586-600. PubMed ID: 27170642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of YadC protein delivered by live attenuated Salmonella as a vaccine against plague.
    Sun W; Olinzock J; Wang S; Sanapala S; Curtiss R
    Pathog Dis; 2014 Mar; 70(2):119-31. PubMed ID: 23913628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. D27-pLpxL, an avirulent strain of Yersinia pestis, primes T cells that protect against pneumonic plague.
    Szaba FM; Kummer LW; Wilhelm LB; Lin JS; Parent MA; Montminy-Paquette SW; Lien E; Johnson LL; Smiley ST
    Infect Immun; 2009 Oct; 77(10):4295-304. PubMed ID: 19620344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A live attenuated strain of Yersinia pestis ΔyscB provides protection against bubonic and pneumonic plagues in mouse model.
    Zhang X; Qi Z; Du Z; Bi Y; Zhang Q; Tan Y; Yang H; Xin Y; Yang R; Wang X
    Vaccine; 2013 May; 31(22):2539-42. PubMed ID: 23588087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization with recombinant V10 protects cynomolgus macaques from lethal pneumonic plague.
    Cornelius CA; Quenee LE; Overheim KA; Koster F; Brasel TL; Elli D; Ciletti NA; Schneewind O
    Infect Immun; 2008 Dec; 76(12):5588-97. PubMed ID: 18794281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Yersinia pestis caf1 variants and the limits of plague vaccine protection.
    Quenee LE; Cornelius CA; Ciletti NA; Elli D; Schneewind O
    Infect Immun; 2008 May; 76(5):2025-36. PubMed ID: 18347051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquisition of maternal antibodies both from the placenta and by lactation protects mouse offspring from Yersinia pestis challenge.
    Qi Z; Zhao H; Zhang Q; Bi Y; Ren L; Zhang X; Yang H; Yang X; Wang Q; Li C; Zhou J; Xin Y; Yang Y; Yang H; Du Z; Tan Y; Han Y; Song Y; Zhou L; Zhang P; Cui Y; Yan Y; Zhou D; Yang R; Wang X
    Clin Vaccine Immunol; 2012 Nov; 19(11):1746-50. PubMed ID: 22933398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.